Research breakthrough edges first-ever CMV vaccine closer

A research breakthrough may have provided scientists with a major step forward in developing the first-ever vaccine against cytomegalovirus (CMV). Researchers from the La Jolla Institute for Allergy & Immunology and Cardiff University discovered that a specific human CMV protein, known as UL141, blocked the cell-surface expression of TNF-related apoptosis-inducing ligand (TRAIL) death receptors normally involved in destroying infected cells. …